217 related articles for article (PubMed ID: 34347736)
1. Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis.
Rogger TM; De Marchi G; Brozzi L; Amodio A; Orsolini G; de Pretis N; Conti Bellocchi MC; Crinò SF; Gabbrielli A; Ciccocioppo R; Frulloni L
Pancreas; 2021 Jul; 50(6):879-881. PubMed ID: 34347736
[TBL] [Abstract][Full Text] [Related]
2. Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease.
Minaga K; Watanabe T; Hara A; Kamata K; Omoto S; Nakai A; Otsuka Y; Sekai I; Yoshikawa T; Yamao K; Takenaka M; Chiba Y; Kudo M
Sci Rep; 2020 Sep; 10(1):14879. PubMed ID: 32938972
[TBL] [Abstract][Full Text] [Related]
3. Serum free light chain assessment in type 1 autoimmune pancreatitis.
Ikemune M; Uchida K; Tsukuda S; Ito T; Nakamaru K; Tomiyama T; Ikeura T; Naganuma M; Okazaki K
Pancreatology; 2021 Apr; 21(3):658-665. PubMed ID: 33741268
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment.
Okazaki K
Dig Dis Sci; 2019 Sep; 64(9):2385-2394. PubMed ID: 31363956
[TBL] [Abstract][Full Text] [Related]
5. IgG4-related autoimmune pancreatitis and sclerosing cholangitis: A case report and literature review.
Wang N; Zhu P; Xiang Y; Tao L; Huang T; Feng Z
Medicine (Baltimore); 2024 Apr; 103(17):e37922. PubMed ID: 38669380
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in IgG4-related autoimmune pancreatitis.
Yang X; Zhou H; Wang W; Yan C; Ji G
Pathol Res Pract; 2024 May; 257():155331. PubMed ID: 38678849
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
[TBL] [Abstract][Full Text] [Related]
8. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
Majumder S; Mohapatra S; Lennon RJ; Piovezani Ramos G; Postier N; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Chari ST; Topazian MD; Witzig TE
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
[TBL] [Abstract][Full Text] [Related]
9. Significant CA 19-9 elevation in IgG4-related autoimmune pancreatitis - A diagnostic dilemma.
Farrukh L; Akhtar MF; Waqar HH; Peredo-Wende R
Am J Med Sci; 2024 Jan; 367(1):67-71. PubMed ID: 37714269
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease.
Minaga K; Watanabe T; Hara A; Yoshikawa T; Kamata K; Kudo M
Front Immunol; 2021; 12():713779. PubMed ID: 34367181
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease.
Hara A; Watanabe T; Minaga K; Yoshikawa T; Kamata K; Kudo M
World J Gastroenterol; 2021 May; 27(19):2257-2269. PubMed ID: 34040320
[TBL] [Abstract][Full Text] [Related]
12. Understanding autoimmune pancreatitis: Clinical features, management challenges, and association with malignancies.
Christodoulidis G; Kouliou MN; Koumarelas KE
World J Gastroenterol; 2024 Apr; 30(15):2091-2095. PubMed ID: 38681985
[TBL] [Abstract][Full Text] [Related]
13. Recent progress on the treatment of type 1 autoimmune pancreatitis and IgG4-related disease.
Okazaki K; Ikeura T; Uchida K
Mod Rheumatol; 2023 Mar; 33(2):237-241. PubMed ID: 35737955
[TBL] [Abstract][Full Text] [Related]
14. Immunostaining With Immunoglobulin G Subclass Antibody Cocktail for Diagnosis of Type 1 Autoimmune Pancreatitis.
Nakata R; Uehara T; Iwaya M; Asaka S; Kobayashi S; Sugano M; Higuchi K; Kusama Y; Nakazawa K; Nakaguro M; Kobayashi M; Tateishi A; Makino M; Kawaguchi K; Maejima T; Ishii K; Sano K; Shimojo H; Hori A; Otsuki T; Hamano H; Kawa S; Ota H
Int J Surg Pathol; 2020 Dec; 28(8):844-849. PubMed ID: 32456567
[TBL] [Abstract][Full Text] [Related]
15. [The clinical characteristics of 346 patients with IgG
Zhang PP; Zhao JZ; Wang M; Feng RE; Liu XW; Lai XM; Li XJ; Zeng JG; Shi HJ; Zhu HD; Xue W; Zhang H; Chen YY; Fei LY; Peng XF; Zeng FC; Zhang YM; Zhang W
Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):644-649. PubMed ID: 28870031
[No Abstract] [Full Text] [Related]
16. Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis.
Paik WH; Ryu JK; Park JM; Song BJ; Park JK; Kim YT; Lee K
World J Gastroenterol; 2013 Jul; 19(25):4031-8. PubMed ID: 23840149
[TBL] [Abstract][Full Text] [Related]
17. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Liu Y; Zhang Y; Bian W; Fu J; Sun X; Chen D; Chen J; Zhao X; Li Y; Zhang W; Li Z
Clin Rheumatol; 2020 Feb; 39(2):491-497. PubMed ID: 31848912
[TBL] [Abstract][Full Text] [Related]
19. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
20. Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
Miki M; Fujimori N; Oono T; Kawabe K; Ohno A; Matsumoto K; Teramatsu K; Tachibana Y; Ogawa Y
J Dig Dis; 2019 Mar; 20(3):152-158. PubMed ID: 30701685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
